Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-09-15
Blomquist Denise L. Files Medtronic plc (MDT) Form 4 - September 15, 2026
Blomquist Denise L. sold 600 MDT shares in this Form 4 filing, reported to the SEC on 2026-09-15.
- Insider
- Blomquist Denise L.
- Issuer
- Medtronic plc MDT · NYSE
- Filed
- Period
- 2026-09-15
- Accession
- 0002061393-26-000014
- Source
- Official filing on sec.gov ↗
Transactions (1)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Blomquist Denise L. | 2026-09-15 | Sell | 600 | $0.00 | $0.00 | Direct |
| Net change | −600 | $0.00 | ||||
About Medtronic plc
Medtronic plc is a global medical technology company that develops, manufactures, and sells device-based therapies and healthcare solutions. Its portfolio spans cardiovascular care, neuroscience, medical surgical products, and diabetes management, supporting the diagnosis, treatment, and monitoring of a wide range of chronic and complex conditions. Medtronic supplies hospitals, clinics, physicians, and other healthcare providers with products such as cardiac rhythm devices, neuromodulation systems, surgical instruments, insulin pumps, and patient monitoring technologies. The company serves healthcare systems across the United States and international markets, making it an important participant in modern medical device supply chains and clinical care delivery. Headquartered in Dublin, Ireland, Medtronic plc focuses on technologies used in everyday care and advanced procedures, helping healthcare professionals address conditions across many specialties.
Track MDT insider activity
Get alerted when Medtronic plc executives buy or sell their shares.